Maseno University Repository

Intermittent Screening and Treatment or Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine Versus Intermittent Preventive Treatment With Sulfadoxine …

Show simple item record

dc.contributor.author Meghna Desai, Julie Gutman, Anne L’lanziva, Kephas Otieno, Elizabeth Juma, Simon Kariuki, Peter Ouma, Vincent Were, Kayla Laserson, Abraham Katana, John Williamson, Feiko O ter Kuile
dc.date.accessioned 2021-01-08T10:53:08Z
dc.date.available 2021-01-08T10:53:08Z
dc.date.issued 2016
dc.identifier.uri https://repository.maseno.ac.ke/handle/123456789/3515
dc.description.abstract In sub-Saharan Africa, there are >32 million pregnancies annually. As this is a malaria-endemic region, it is estimated approximately 12 million women who have live births (45% of live births) would be exposed to malaria infection each year. The World Health Organization (WHO) recommends intermittent preventive treatment with sulfadoxine-pyrimethamine during the second and third trimester for parturients living in malaria-endemic areas. Although this strategy has been effective, concerns are being raised due to an increase in parasite resistance. The aim of this current study was to assess the efficacy and safety of 2 alternative strategies: intermittent screening with malaria rapid diagnostic tests and treatment of women who test positive with dihydroartemisinin-piperaquine, and intermittent preventive treatment with dihydroartemisinin-piperaquine. en_US
dc.publisher LWW en_US
dc.title Intermittent Screening and Treatment or Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine Versus Intermittent Preventive Treatment With Sulfadoxine … en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Maseno University Repository


Browse

My Account